Effects of verapamil on the binding properties of rat heart muscarinic receptors: evidence for an allosteric site. 1984

M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe

The calcium channel antagonist verapamil is known to inhibit competitively antagonist binding to rat heart muscarinic receptors. The present data suggest that this drug recognized two binding sites on the muscarinic receptors: 1) an allosteric site modulating the tracer dissociation rates and 2) the muscarinic drug binding site. The affinity of verapamil for the allosteric site and the efficacy of its effect on muscarinic ligand dissociation rates depended on the ligand studied.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D000495 Allosteric Site A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties. Allosteric Sites,Site, Allosteric,Sites, Allosteric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012602 Scopolamine Derivatives Analogs or derivatives of scopolamine. Scopolamines,Derivatives, Scopolamine
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
January 1998, Journal of physiology, Paris,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
December 2005, Molecular pharmacology,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
January 1983, Research communications in chemical pathology and pharmacology,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
December 2009, BMC pharmacology,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
October 1996, European journal of pharmacology,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
October 1994, Molecular pharmacology,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
January 2018, Cellular signalling,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
January 1980, Advances in biochemical psychopharmacology,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
August 1981, The Journal of pharmacology and experimental therapeutics,
M Waelbroeck, and P Robberecht, and P De Neef, and J Christophe
January 1995, Molecular pharmacology,
Copied contents to your clipboard!